United States · Platforms & data · Investing.com

Stifel reiterates Codexis stock rating on pharma demand strength

Published by Investing.com · United States 2 h ago

Stifel reiterates Codexis stock rating on pharma demand strength — Investing.com

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

Denali Therapeutics Targets All Eligible Hunter Disease Patients as Pipeline Milestones Near

Fortress Biotech GAAP EPS of -$0.23 beats by $0.04, revenue of $19.16M misses by $2.41M

What Is Going on With Micron Stock on Friday?

The Motley Fool

How Much Is Nvidia Stock Worth Without Jensen Huang?

The science of vaccines is rapidly advancing — despite the anti-vax movement

Novo Nordisk Seeks FDA, EMA Approval For Sickle Cell Disease Treatment – Here Are The Key Takeaways